G16S (p.Gly16Ser) variant of VIM (Vimentin)

G16S (p.Gly16Ser) in VIM (Vimentin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cataract 30. The available variant effect predictions contribute to a CATVariant prioritization score of 0.63 / 1. The record also includes population frequency data and structural context.

G16S (p.Gly16Ser) variant details